Neurology and Movement Disorders
Clinical research at Klinikum rechts der Isar der TU Muenchen AöR includes idiopathic Parkinson’s disease and corticobasal syndrome, with interest in symptomatic treatment, neurodegeneration, and biomarkers linked to disease progression.
- Parkinson’s disease
- Corticobasal syndrome
- Neurofilament light chain
- ROCK inhibition
The neurological portfolio also reflects work on therapies aimed at motor and non-motor symptom control, alongside molecular measures relevant to neurodegenerative disease.
Hematology and Oncology
The sponsor supports studies in non-Hodgkin lymphomas, including lymphoproliferative cancers and CXCR4-directed approaches that combine imaging and treatment-oriented research.
- Non-Hodgkin lymphoma
- Lymphoproliferative malignancies
- CXCR4-targeted theranostics
- Autologous stem cell transplantation
Research activity in this area also includes advanced treatment concepts for hematologic cancers and response assessment in aggressive disease settings.
Dermatology and Inflammatory Skin Disease
Dermatologic research focuses on nummular eczema and related inflammatory skin conditions, with attention to immune-mediated disease control and symptom relief.
- Nummular eczema
- Inflammatory dermatitis
- Dupilumab
- Immune-mediated skin disease
This area reflects interest in targeted management of chronic eczema-associated inflammation and associated clinical outcomes.
Diabetes and Autoimmunity
Another research focus is type 1 diabetes prevention in children with elevated genetic risk, including studies of islet autoantibodies and early immune-related disease development.
- Type 1 diabetes risk
- Islet autoimmunity
- Childhood prevention
- COVID-19 vaccination
The portfolio includes pediatric immune prevention research with relevance to early identification of autoimmune progression.
